# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Yi Chen maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and raises the price target fro...
Maxim Group analyst Anthony Vendetti maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and raises the price target from $...
Sensus Healthcare (NASDAQ:SRTS) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $(0...
First veterinary commercial sale of the SRT-100 outside the U.S.BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- Sensus Healt...